Home › Funds › UBS Group AG › CGON
UBS Group AG position in CGON
CG ONCOLOGY INC · Health Care
Latest position (Q2 2026)977.70K sh
Reported value held$69.47M
Portfolio Weight0.01%
First reportedQ1 2024
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2024 | 23.32K | $1.02M | New |
| Q2 2024 | 78.08K | $2.46M | Add |
| Q3 2024 | 86.53K | $3.26M | Add |
| Q4 2024 | 1.01M | $29.08M | Add |
| Q1 2025 | 1.70M | $41.75M | Add |
| Q2 2025 | 2.23M | $57.96M | Add |
| Q3 2025 | 2.13M | $85.65M | Reduce |
| Q4 2025 | 1.92M | $79.87M | Reduce |
| Q1 2026 | 1.31M | $88.79M | Reduce |
| Q2 2026 | 977.70K | $69.47M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding CGON
- BlackRock Inc 6.26M sh · $444.51M · Q2 2026
- Wellington Management Group 5.32M sh · $378.32M · Q2 2026
- Fidelity Management & Research (FMR) 4.16M sh · $295.67M · Q2 2026
- Vanguard Group 6.54M sh · $271.52M · Q4 2025
- Geode Capital Management 2.15M sh · $153.02M · Q2 2026
- Franklin Resources 1.31M sh · $93.28M · Q2 2026
- Morgan Stanley 1.18M sh · $83.63M · Q2 2026
- Bank of America Corp 984.92K sh · $69.98M · Q2 2026
- Goldman Sachs Group 857.71K sh · $60.94M · Q2 2026
- Northern Trust Corp 677.91K sh · $48.17M · Q2 2026
- Charles Schwab Investment Management 627.18K sh · $44.56M · Q2 2026